Ladarixin With Sotorasib in Advanced NSCLC
Ladarixin With Sotorasib in Advanced NSCLC
Recruiting · NCT05815173 · Registry updated 2025-12-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ladarixin With Sotorasib in Advanced NSCLC | Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation | Recruiting | Phase 1 | 2025-12-30 | NCT05815173 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| NYU Langone Health | 359 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| NYU Langone Health | New York | United States | 2 |
| NYU Langone Health | New York | United States | 23 |
| NYU Langone Health | Mineola | United States | 6 |
| NYU Langone Health | New York | United States | 403 |
| NYU Langone Health | New Hyde Park | United States | 1 |
| NYU Langone Health | Garden City | United States | 3 |